Active substance
Technetium tc 99m sestamibi kit
- US FDA 6
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CARDIOLITE | N/A | injectable · injection | SHINE | Prescription | 21 Dec 1990 |
| TECHNETIUM TC 99M SESTAMIBI | N/A | injectable · injection | CURIUM | Prescription | 22 Sep 2008 |
| TECHNETIUM TC 99M SESTAMIBI | N/A | injectable · injection | CARDINAL HEALTH 414 | Prescription | 28 Apr 2009 |
| TECHNETIUM TC 99M SESTAMIBI | N/A | injectable · injection | JUBILANT DRAXIMAGE | Prescription | 29 Apr 2009 |
| MIRALUMA | N/A | injectable · injection | SHINE | Discontinued | 21 Dec 1990 |
| TECHNETIUM TC 99M SESTAMIBI | 10-30mCi | injectable · injection | SUN PHARM INDS INC | Discontinued | 10 Jul 2009 |
Safety signals and safety-related labeling changes
- US FDA 4 Dec 2019 CARDIOLITE — safety-related labeling change
Labeling sections changed: Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.